共 50 条
- [12] Corticosteroid sparing effects of ustekinumab therapy for ulcerative colitis through 2 years: UNIFI long-term extension JOURNAL OF CROHNS & COLITIS, 2020, 14 : S113 - S114
- [13] Corticosteroid-Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 4 Years: UNIFI Long-Term Extension AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S577 - S577
- [14] Efficacy and safety of ustekinumab for Ulcerative Colitis through 4 years in Asian patients: Final results from the sub-population of UNIFI long-term extension JOURNAL OF CROHNS & COLITIS, 2023, 17 : 566 - 568
- [17] Efficacy and safety of long-term treatment with ustekinumab in moderate-severe ulcerative colitis patients with delayed response to ustekinumab induction: Results from UNIFI 2-year long-term extension JOURNAL OF CROHNS & COLITIS, 2020, 14 : S476 - S477
- [18] Association Between Efficacy and Long-Term Outcomes: Four Year Results From the UNIFI Study of Ustekinumab in Ulcerative Colitis AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S811 - S811
- [19] Long-term Efficacy and Safety of Azathioprine in Ulcerative Colitis JOURNAL OF CROHNS & COLITIS, 2015, 9 (02): : 191 - 197